United StatesBreaking News

Palantir CTO Shyam Sankar joined Tyler Kendall on Bloomberg Open Interest. He argues the Pentagon has dramatically accelerated defense tech adoption and says the 2027 budget marks a turning point for AI-powered warfare. He also warns that America's biggest AI challenge isn't China, but rather it's turning innovation into economic prosperity while staying ahead in the global technology race.

Despite cooler inflation data, KPMG Chief Economist Diane Swonk says the fight against inflation is far from over. She joined Bloomberg Open Interest to talk about why the Fed may need two more rate hikes. She says geopolitical tensions could reignite food and energy inflation, and warns the AI-driven market rally is masking growing financial stress for everyday consumers.

Johnson & Johnson reported $25.3 billion in revenue in the second quarter, surpassing the average estimate from analysts, but disappointing demand for its medical devices overshadowed better-than-expected drug sales. Madison Muller reports on Bloomberg Television.

Former US Ambassador to China Nicholas Burns speaks to Bloomberg News's David Gura on Tuesday at the Aspen Security Forum about the perils of Nvidia's advanced AI chips being shipped to China as well as the geopolitical and global market consequences in the wake of the collapse of the US-Iran interim peace deal. Speaking on the sidelines of the Aspen Security Forum in Colorado, Burns says President Trump is "making a major mistake" by allowing Nvidia to sell its products to one of the US's biggest rivals.

Cintas (NASDAQ:CTAS) reported fiscal Q4 2026 net income of $511 million and diluted EPS of $1.26 on revenue of $2.91 billion.

VivoSim Labs (NASDAQ:VIVS) received $5 million from Eli Lilly (NYSE:LLY) after first Phase 2 dosing and could earn another $45 million.

Community Trust Bancorp (NASDAQ:CTBI) reported record Q2 2026 net income of $29.6 million and basic earnings of $1.64 per share.

Eos Energy Enterprises (NASDAQ:EOSE) expects record Q2 revenue of $68–$69 million as shipments more than tripled year over year.

Intensity Therapeutics (NASDAQ:INTS) restarted dosing in its 61-patient INVINCIBLE-4 trial, testing INT230-6 before standard treatment for presurgical TNBC.

Halliburton (NYSE:HAL) announced it secured a multi-year contract from Aramco to support unconventional gas development programs in Saudi Arabia.

Morgan Stanley's stock traders beat expectations to set another quarterly record as the firm earned $6.3 billion from equity trading in the period, a 69% jump that topped its previous all-time high from the first quarter. Jonathan Ferro and Lisa Abramowicz examine the results on "Bloomberg Surveillance."

Sify Technologies (NASDAQ:SIFY) reported Q1 FY2026-27 revenue of ₹12.352 billion, up 15%, with a ₹65 million profit.